Patents by Inventor Marcel Kling

Marcel Kling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blockade of voltage dependent sodium channels
    Patent number: 7790761
    Abstract: Compounds of Formula I and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: September 7, 2010
    Assignee: University College London
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart
  • Nicotinamide-based kinase inhibitors
    Publication number: 20070060619
    Abstract: A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
    Type: Application
    Filed: December 15, 2003
    Publication date: March 15, 2007
    Applicant: CYTOPIA PTY LTD
    Inventors: Christopher Burns, Marcel Kling
  • Blockade of voltage dependent sodium channels
    Publication number: 20060100248
    Abstract: Compounds of Formula I and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Application
    Filed: December 21, 2005
    Publication date: May 11, 2006
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart
  • Blockade of voltage dependent sodium channels
    Patent number: 7009056
    Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 7, 2006
    Assignee: University College London
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart
  • Blockade of voltage dependent sodium channels
    Publication number: 20030171403
    Abstract: Compounds of formula (1), and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Application
    Filed: February 25, 2003
    Publication date: September 11, 2003
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart